Sales and Marketing

Showing 15 posts of 11524 posts found.

ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
shutterstock_232245868

Personalised medicine to drive global lung cancer market to 2020

November 29, 2016 Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer

According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …

FDA orphan drug designation doubles PhaseRx shares

November 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx

PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
syqe-marijuana_inhaler

Teva to market world’s first medical marijuana inhaler

November 28, 2016 Research and Development, Sales and Marketing

Israel’s Teva Pharmaceutical Industries has signed an agreement with Tel Aviv-based biotech Syqe Medical for the distribution and marketing of …
kymab

Chinese investors push Kymab backing to $100 million

November 28, 2016 Sales and Marketing Bill & Melina Gates Foundation, China, kymab

Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …
pfizer_building2web

Pfizer scraps €400m Dublin facility expansion

November 28, 2016 Manufacturing and Production, Sales and Marketing Pfizer, bococizumab

Pfizer has U-turned on its intention to bolster operations at its Grange Castle, Dublin facility in a 34,500 square-metre expansion …
takeda_tokyo_hq

Takeda gains marketing authorisation for multiple myeloma pill

November 28, 2016 Sales and Marketing Takeda, multiple myeloma

Takeda Pharmaceutical has announced that they have received conditional marketing authorisation for Ninlaro (ixazomib) for treatment of adult patients with …
european_commission_web

GSK applies for EU approval for shingles vaccine

November 28, 2016 Sales and Marketing European Commission, GSK, GlaxoSmithKline, Shingrix, shingles

After filing for FDA approval in October, GlaxoSmithKline has now applied for approval from the European Commission (EC) for its …
uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …

J&J reportedly poised to acquire Europe’s biggest biotech

November 25, 2016 Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition

Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …

GSK reaches endgame of race to develop anaemia drug

November 25, 2016 Research and Development, Sales and Marketing AstraZeneca, Daprodustat, GSK, GlaxoSmithKline, anaemia

GlaxoSmithKline has announced that they will begin Phase 3 development of their anaemia drug, daprodustat. The drug is an oral …
deb_lancaster

Insider interview: Roche discusses efficacy of CDF and NICE

November 25, 2016 Medical Communications, Sales and Marketing CDF, NICE, Roche

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …
nice_aerial

Lowered price wins NICE approval for Janssen leukaemia treatment

November 25, 2016 Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …
The Gateway to Local Adoption Series

Latest content